MetaCap

Omada Health (OMDA) vs GeneDx (WGS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Omada Health (OMDA) has outperformed GeneDx (WGS) over the past year, losing 36.2% versus a loss of 69.0%. GeneDx is the larger company by market cap ($1.36 billion vs $736.4 million), about 1.9 times the size, while Omada Health is growing revenue faster (+53.2% vs +40.0%). On valuation, Omada Health trades at a lower forward P/E (17.2x vs 34.9x for GeneDx).

Omada Health converts more of its revenue into profit, with a net margin of -4.9% versus -4.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OMDA-36.18%WGS-68.98%
+40%-21%-82%
Nov 21, 20251 yearNov 20, 2026
OMDA-48.39%WGS-36.92%
+141%+40%-60%
Jun 2, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OMDA versus WGS key metrics
MetricOMDAWGS
Share price$11.87$45.46
Market cap$736.39M$1.36B
1-day change-5.04%-7.68%
YTD return-24.78%-65.05%
1-year return-36.18%-68.98%
5-year return—-80.01%
P/E ratio (TTM)29.68—
Forward P/E17.1834.93
EPS (TTM)$0.40$-3.76
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$260.21M$427.54M
Revenue growth (YoY)+53.24%+39.97%
Net income (latest FY)$-12.78M$-21.02M
Gross margin65.69%69.74%
Operating margin-4.60%-3.06%
Net margin-4.91%-4.92%
52-week high$25.45$170.87
52-week low$10.28$32.21
Distance from 52-week high-53.36%-73.39%
Analyst consensusbuystrong_buy
Avg. price target upside+123.25%+80.38%
Average volume1.33M869.34K
Shares outstanding62.04M29.97M
Employees9801,300
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • OMDA has outperformed WGS by 32.8 percentage points over the past year.
  • Omada Health grew revenue faster in its latest fiscal year (+53.24% vs +39.97%).

About Omada Health

OMDA stock →

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.

Health Care · Medical/Nursing Services · 980 employees

About GeneDx

WGS stock →

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.

Health Care · Medical/Nursing Services · 1,300 employees

OMDA vs WGS FAQ

Which is bigger, Omada Health or GeneDx?

GeneDx (WGS) is larger, with a market capitalization of $1.36B compared with $736.39M for Omada Health (OMDA).

Which stock has performed better over the past year, OMDA or WGS?

OMDA returned -36.18% over the past 12 months, compared with -68.98% for WGS (price return, excluding dividends). Past performance does not predict future results.

Are Omada Health and GeneDx in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons